Press Releases

Summary ToggleProLung, Inc. Releases Communication Urging Stockholders Not to Respond to Consent Solicitation by Steven C. Eror

August 15, 2018

SALT LAKE CITY, UT / ACCESSWIRE / August 15, 2018 / ProLung, Inc. (“ProLung” or the “Company”) today released a communication urging stockholders not to respond to the consent solicitation by Steven C. Eror. The Company announced that stockholders will soon receive consent revocation materials and

Summary ToggleProLung Recognized with "2018's Most Innovative Predictive Analytics Award" by Corporate Vision

June 18, 2018

SALT LAKE CITY, UT / ACCESSWIRE / June 18, 2018 / Corporate Vision announced that ProLung, Inc. ("ProLung" or the "Company") is their "2018's Most Innovative Predictive Analytics Award - USA" winner.   Andy Robertson, Chief Marketing Officer of ProLung® stated, "Earning this innovation award is

Summary ToggleProLung Named Top Ten Analytics Solution Provider by Pharma Tech Outlook

May 30, 2018

ProLung is very excited to have our Company and product, the ProLung Test™, featured in Pharma Tech Outlook’s May 2018 Special Issue on Pharma Analytics. Named as a Top Ten Analytics Solution Provider in 2018, we are eager to continue preparing for commercialization and pursuing a bold strategy to

Summary ToggleProLung recognized with '2018 Utah Innovation Award' by Stoel Rives and Utah Technology Council

May 01, 2018

SALT LAKE CITY, UT / ACCESSWIRE / May 1, 2018 / Stoel Rives LLP and the Utah Technology Council (UTC) announced that ProLung, Inc. (''ProLung'' or the ''Company'') is their 2018 Utah Innovation Award winner for the ''Life Science - BioTech'' category. Steven Eror, President and CEO of ProLung®

Summary ToggleMDDI Feature: ProLung Breathes Life Into Lung Cancer Detection

April 30, 2018

ProLung is hoping to change the way lung cancer is detected through its test that measures the difference in conductivity between malignant and benign lung tissue.   Courtesy of ProLung Three years ago, the U.S. Preventative Services Task Force and Centers for Medicare and Medicaid Services added

Summary ToggleProLung Recognized with '2018 Biotechnology Award' by Global Health & Pharma

April 23, 2018

SALT LAKE CITY, UT / ACCESSWIRE / April 23, 2018 / Global Health and Pharma (GHP) announced that ProLung, Inc. (''ProLung'' or the ''Company'') is their 2018 Biotechnology Award winner for '' Best Medical Technology Company 2018 - USA and Best Lung Cancer Predictive Analytics Risk Testing Platform

Summary ToggleProLung Featured in MedTech Strategist’s “Start-Ups to Watch”

April 02, 2018

ProLung is honored to be featured in a special issue of MedTech Strategist for innovative technologies and influential companies. As a “Start-Up to Watch”, ProLung CEO and co-founder, Steven C. Eror, shares the development behind ProLung’s solution to an unmet clinical need for lung cancer.

Summary ToggleProLung, Inc. Appoints Mark Anderson, CPA as Chief Financial Officer

March 28, 2018

ProLung, Inc. is focused on making a difference in time for lung cancer patients with its innovative predictive analytics technology and non-invasive tests for the risk stratification of indeterminate pulmonary nodules. Today ProLung announces the appointment of Mark V. Anderson, CPA as Chief Financial Officer.

Summary ToggleProLung Test™ by ProLung, Inc. named Finalist in 2018 Utah Innovation Awards

March 26, 2018

We are excited to announce our ProLung Test™ has been selected as a finalist in the Life Science-Biotech category for the 2018 Utah Innovation Awards, presented by Stoel Rives LLP and the Utah Technology Council! ProLung will be attending the Awards Dinner in Salt Lake City later this month.

Summary ToggleProLung, Inc. Appoints Rex Yung, MD as Chief Scientific Officer

March 19, 2018

ProLung, Inc., which is focused on making a difference in time for lung cancer patients with its innovative predictive analytics technology and non-invasive tests for the risk stratification of indeterminate pulmonary nodules, announces the appointment of Rex Yung, MD, FCCP as Chief Scientific Officer.